title: [News in oncology. The drug Zelboraf has been registered in the EU for treatment of patients with aggressive forms of melanoma].
authors.affiliation: viktor.sebek@roche.com
authors.forename: Viktor
authors.initials: V
authors.lastname: Sebek
mesh_terms: D017277:Drug Approval; D005062:European Union; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib